Trial Profile
Comparison of Tolvaptan and Carperitide in acute decompensated heart failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2013
Price :
$35
*
At a glance
- Drugs Carperitide (Primary) ; Tolvaptan (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- 25 Nov 2013 New trial record